MedPath

A novel approach to improving health outcomes among young adults with type 1 diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes
Nutritional, Metabolic, Endocrine
Type 1 diabetes mellitus
Registration Number
ISRCTN74114336
Lead Sponsor
I Galway
Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32511803/ protocol (added 06/01/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35260182/ (added 14/03/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

1. Physician confirmed diagnosis of T1D for more than 12 months.
2. Age between 18-25 years on the date of recruitment.
3. Access to a mobile phone device.

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Recruitment of diabetes centres is measured using documentation of the number of invitations sent, the number of refusals and number of acceptances at beginning of the trial.<br> 2. Recruitment of patients is measured using documentation of the number of invitations sent, the number of initial responses, the number of follow-up phone-calls required, the number of refusals and the number of acceptances at the beginning of the trial.<br> 3. Attrition is measured using the number of participants who consent to participate and who remain in the study until the end of follow up at 12 months.<br> 4. Missing data in returned questionnaires is measured at month 0 and month 12.<br> 5. The comprehensibility and acceptability of all questionnaires is measured by asking participants; how the questionnaires might be improved, and how long they took to complete at month 0 and month 12.<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath